Epidemiology and genotyping of patients with chronic hepatitis B: genotype shifting observed in patients from Central Europe

• Autorzy: Bissinger A.L. , Fehrle C. , Werner C.R. , Lauer U.M. , Malek N.P. , Berg C.P.
• Języki publikacji: EN

Abstrakty

EN

Background: Knowledge on HBV prevalence and genotype distribution in Europe still is hampered by lack of coherent data sampling, small numbers of patients studied so far, and also modern times migration which influences both parameters in a quite dynamic manner. To find out whether HBV prevalence and genotype distribution has undergone any significant changes over the past decades, we have analyzed our cohort of HBV patients. Methods: Retrospective analysis of virological data and correlation with the epidemiological backgrounds of 408 chronically HBV-infected patients, followed in the year 2009 at Tübingen Virus Hepatitis Center, Germany. Results: A background of migration was found in more than 80% of our HBV patients, displaying an origin from 41 different countries. Analysis of the genotypes revealed that genotype A predominated only among patients from Central Europe with 55.8% while genotype D, known to be most common worldwide, was most prevalent in patients born in Eastern and Southern Europe, Central Asia and Middle East, exhibiting a range from 81% to 94%. In Central Europe, genotype A was particularly seen in older patients as compared to genotype D that predominated in the younger patients. Conclusions: These data suggest that Central Europe is straight on its way to switch from genotype A to genotype D. One reason for this significant shift may be related to the ongoing European and global migration flow.

• Wydawca: -
• Czasopismo: Polish Journal of Microbiology
• Rocznik: 2015
• Tom: 64
• Numer: 1
• Opis fizyczny: p.15-21,fig.,ref.

Twórcy

autor

Bissinger A.L.

• Medical Clinic, Department of Gastroenterology, Hepatology, and Infectiology, Medical University Hospital Tubingen, Tubingen, Germany
• Institute of Tropical Medicine, Medical University Hospital Tubingen, Tubingen, Germany

autor

Fehrle C.

• Medical Clinic, Department of Gastroenterology, Hepatology, and Infectiology, Medical University Hospital Tubingen, Tubingen, Germany
• Steinenberg Clinic, Department of Surgery, Reutlingen,Germany

autor

Werner C.R.

• Medical Clinic, Department of Gastroenterology, Hepatology, and Infectiology, Medical University Hospital Tubingen, Tubingen, Germany

autor

Lauer U.M.

autor

Malek N.P.

• Medical Clinic, Department of Gastroenterology, Hepatology, and Infectiology, Medical University Hospital Tubingen, Tubingen, Germany

autor

Berg C.P.

• Medical Clinic, Department of Gastroenterology, Hepatology, and Infectiology, Medical University Hospital Tubingen, Tubingen, Germany

Bibliografia

• Araujo N.M., R. Waizbort and A. Kay. 2011. Hepatitis B virus infection from an evolutionary point of view: how viral, host, and environmental factors shape genotypes and subgenotypes. Infect. Genet. Evol. 11: 1199–1207.
• Congly S.E., P. Wong, S.A. Al-Busafi, K. Doucette, S.K. Fung, P. Ghali, K. Fonseca, R.P. Myers, C. Osiowy and C.S. Coffin. 2013. Characterization of hepatitis B virus genotypes and quantitative hepatitis B surface antigen titres in North American tertiary referral liver centres. Liver Int. 33: 1363–1369.
• Cornberg M., U. Protzer, J. Petersen, H. Wedemeyer, T. Berg, W. Jilg, A. Erhardt, S. Wirth, C. Sarrazin, M.M. Dollinger and others. 2011. Aktualisierung der S3-Leitlinie zur Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion, AWMF-Register-Nr.: 021/011. Z. Gastroenterol. 49: 871–930.
• European Association for the Study of the Liver. 2012. EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection. J. Hepatol. 57: 167–185.
• Fischer C., S. Mauss E. Zehnter, B. Bokemeyer, R. Heyne and D. Hüppe. 2012. Epidemiology and clinical characteristics of patients with chronic hepatitis B (CHB) in Germany – Results of a nationwide cross-sectional study. Z. Gastroenterol. 50: 22–29.
• Flink H.J., M. van Zonneveld, B.E. Hansen, R.A. de Man, S.W. Schalm and H.L.Janssen. 2006. Treatment with Peg-interferon alpha-2b for HBeAg-positive chronic hepatitis B: HBsAg loss is associated with HBV genotype. Am. J. Gastroenterol. 101: 297–303.
• Guirgis B.S., R.O. Abbas and H.M. Azzazy. 2010. Hepatitis B virus genotyping: current methods and clinical implications. Int. J. Infect. Dis. 14: e941–953.
• Lin C.L. and J.H. Kao. 2011. The clinical implications of hepatitis B virus genotype: Recent advances. J. Gastroenterol. Hepatol. 26s1: 123–130.
• Mutterschafts-Richtlinien. 2012. Richtlinien des Bundesausschusses der Ärzte und Krankenkassen über die ärztliche Betreuung während der Schwangerschaft und nach der Entbindung. Bundesanzeiger. http://www.g-ba.de/downloads/62-492-665/Mu-RL_2012-10-18.pdf. Accessed 11 Jan 2013.
• Niederau C. 2007. Epidemiologie der Hepatitis-B-Virusinfektionen in Deutschland. Med. Klin. 102: 351–357.
• Norder H., A.M. Couroucé, P. Coursaget, J.M. Echevarria, S.D. Lee, I.K. Mushahwar, B.H. Robertson, S. Locarnini and L.O. Magnius. 2004. Genetic diversity of Hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 47: 289–309.
• Robert Koch Institut (RKI). 2012. Mitteilung der Ständigen Impfkommission am Robert Koch Institut (RKI). Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch Institut, Stand Juli 2012. Epidemiol. Bulletin 30: 283–310.
• Robert Koch Institut (RKI). 2013a. Virushepatitis B und D im Jahr 2012. Epidemiol. Bulletin 29: 259–269.
• Robert Koch Institut (RKI). 2013b. Impfquoten bei der Schuleingangsuntersuchung in Deutschland 2011. Epidemiol. Bulletin 16: 129–133.
• Schaefer S. 2005. Hepatitis B virus: significance of genotypes. J. Viral. Hepatitis 12: 111–124.
• Thierfelder W., W. Hellenbrand, H. Meisel, E. Schreier and R. Dortschy. 2001. Prevalence of markers for hepatitis A, B and C in the German population. Results of the German National Health Interview and Examination Survey 1998. Eur. J. Epidemiol. 17: 429–435.
• World Health Organization (WHO). 2009. Weekly epidemiological record No. 40. 84:405–20. http://www.who.int/wer/2009/wer8440. pdf